Global Rapid Diagnostics Market Size By Product Type (Over-The-Counter (OTC) Rapid Diagnostic Tests, Professional Rapid Diagnostic Tests), By Technology (Immunoassays, Molecular Diagnostics), By Application (Infectious Diseases, Cancer), By End-User (Hospitals and Clinics, Diagnostic Laboratories), By Geographic Scope And Forecast

Rapid Diagnostics Market Size And Forecast

Rapid Diagnostics Market size was valued at USD 204.1 Million in the year 2022 and is projected to reach USD 540.7 Million in 2030, growing at a CAGR of 10.48% from 2023 to 2030.

The growth of the Rapid Diagnostics Market is driven by factors such as the increasing prevalence of infectious diseases, increasing demand for point-of-care testing, growing geriatric population, and increasing adoption of rapid diagnostic tests in home care settings. The infectious diseases segment is expected to hold the largest share of the Rapid Diagnostics Market during the forecast period due to the high demand for rapid diagnostic tests for diseases such as COVID-19, HIV, and influenza.

Geographically, North America is expected to hold the largest share of the Rapid Diagnostics Market, followed by Europe and the Asia-Pacific region. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period due to factors such as the increasing prevalence of infectious diseases, growing demand for point-of-care testing, and growing geriatric population. Overall, the Rapid Diagnostics Market is expected to grow significantly during the forecast period, owing to technological advancements, growing demand for rapid diagnostic tests, and increasing investment in R&D.

Global Rapid Diagnostics Market Definition

The Rapid Diagnostics Market refers to the market for diagnostic tests designed to provide fast and accurate results in a short period of time. Rapid diagnostic tests are typically used to diagnose infectious diseases such as HIV, influenza, and COVID-19, but can also be used to diagnose other conditions such as cancer, heart disease, and pregnancy. Rapid diagnostic tests use a variety of technologies, including immunoassays, molecular diagnostics, and chromatography, to detect the presence of specific biomarkers, such as antigens, antibodies, and nucleic acids, in a patient sample.

These tests are often done at the point of care, such as a doctor’s office or community health center, and can be done in minutes, not hours or days. The Rapid Diagnostics Market includes a wide range of players, including diagnostic test manufacturers, medical device companies, and healthcare providers. The market is driven by factors such as increasing demand for point-of-care testing, the need for rapid and accurate diagnosis of infectious diseases, and the increasing prevalence of chronic diseases. The market is expected to continue to grow as new technologies and tests are developed and as healthcare systems around the world place greater emphasis on preventive care and early disease detection.

Global Rapid Diagnostics Market Overview

The growth of the Rapid Diagnostics Market is driven by several factors, including the increasing prevalence of infectious diseases such as COVID-19, increasing demand for point-of-care testing, and the need for accurate and rapid disease diagnosis. Immunoassays and molecular diagnostics are the most common types of rapid diagnostic tests and are expected to continue to dominate the market. However, there is also significant growth potential for other types of rapid diagnostic tests, such as biosensors and microfluidic devices, which are being developed for a range of applications.

The COVID-19 pandemic has significantly impacted the Rapid Diagnostics Market, with the demand for COVID-19 tests driving the market growth in 2020 and 2021. Although the pandemic is expected to subside over time, it has highlighted the importance of rapid diagnostic tests in the detection and control of infectious diseases, and is likely that this will continue to drive the demand for rapid diagnostic tests in the coming years. Geographically, North America and Europe are the largest markets for rapid diagnostic tests due to well-established healthcare infrastructure and the large adoption of new technologies.

However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period due to factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing demand for point-of-care testing in emerging economies. Overall, the Rapid Diagnostics Market is expected to continue to grow in the coming years, driven by technological advancements, increasing demand for point-of-care testing, and the need for rapid and accurate disease diagnosis.

Global Rapid Diagnostics Market Segmentation Analysis

The Global Rapid Diagnostics Market is segmented into Product Type, Technology, Application, End-User, and Geography.

Rapid Diagnostics Market, By Product Type

• Over-The-Counter (OTC) Rapid Diagnostic Tests
• Professional Rapid Diagnostic Tests

Based on Product Type, the market is segmented into Over-The-Counter (OTC) Rapid Diagnostic Tests and Professional Rapid Diagnostic Tests. OTC rapid diagnostic tests are intended for use by consumers at home, while professional rapid diagnostic tests are used by healthcare providers in clinical settings.

Rapid Diagnostics Market, By Technology

• Immunoassays
• Molecular Diagnostics
• Chromatography
• Others

Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Chromatography, and Others. Immunoassays are the most used technology for rapid diagnostic tests, followed by molecular diagnostics.

Rapid Diagnostics Market, By Application

• Infectious Diseases
• Cancer
• Cardiac Markers
• Pregnancy and Fertility Tests
• Glucose Monitoring
• Others

Based on Application, the market is segmented into Infectious Diseases, Cancer, Cardiac Markers, Pregnancy and Fertility Tests, Glucose Monitoring, and Others. Infectious diseases are the largest segment of the Rapid Diagnostics Market due to the high demand for rapid diagnostic tests for diseases such as COVID-19, HIV, and influenza.

Rapid Diagnostics Market, By End-User

• Hospitals and Clinics
• Diagnostic Laboratories
• Homecare
• Others

Based on End-User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Homecare, and Others. Hospitals and clinics are the largest end users of rapid diagnostic tests due to the large number of patients and the need for rapid diagnosis in the emergency setting.

Rapid Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of Geography, the Global Rapid Diagnostics Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe are the largest markets for rapid diagnostic tests, while Asia Pacific is expected to witness the highest growth rate during the forecast period. Overall, the Rapid Diagnostics Market is a diverse and growing market with a variety of products, technologies, applications, end users, and regions. Segmentation analysis helps to better understand the market and identify opportunities for growth and investment.

Key Players

The “Global Rapid Diagnostics Market” study report will provide valuable insight with an emphasis on the global market including some of the major players of the industry are Abbott Laboratories, Inc., Becton, Dickinson, and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quidel Corporation, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech plc, Frigoríficos De Camariñas S L.

Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In August 2021 – Abbott Laboratories launched its latest point-of-care diagnostic test, the BinaxNOW COVID-19 Ag Card Home Test, which can be used at home without a prescription.
• In March 2021 – Roche announced the launch of its rapid SARS-CoV-2 antigen test, which provides results in just 15 minutes.
• In January 2021 – Quidel Corporation received Emergency Use Authorization (EUA) from the US FDA for its Sofia 2 SARS Antigen FIA, a rapid diagnostic test for COVID-19.
• In October 2020 – BD (Becton, Dickinson, and Company) received Emergency Use Authorization (EUA) from the US FDA for its rapid point-of-care antigen test for COVID-19, which provides results in just 15 minutes.
• In September 2020 – Danaher Corporation announced the acquisition of Cytiva, a biotechnology company that develops and manufactures a range of rapid diagnostic tests.
• In July 2020 – Bio-Rad Laboratories has received Emergency Use Authorization (EUA) from the US FDA for its SARS-CoV-2 Droplet Digital PCR (ddPCR) test, which provides highly accurate and precise results in just hours.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors.
• Provision of market value (USD Billion) data for each segment and sub-segment.Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market.
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region.
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled.
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players.
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions.
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis.
• It provides insight into the market through Value Chain.
• Market dynamics scenario, along with growth opportunities of the market in the years to come.6-month post-sales analyst support.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.